Ines Macias-Perez, Ph.D., is a clinical research professional with extensive experience in drug development and program management. In her role serving as the Director of Product Development at Cumberland Pharmaceuticals, she oversees the strategic planning, execution, and management of clinical and nonclinical programs for the company's product portfolio.

Prior to her role at Cumberland, Dr. Macias-Perez held leadership positions at the Radiosurgical Research Institute, where she served as the Executive Director, and Berg Pharma, where she was the Clinical Research Director. She also held positions at renowned institutions Sarah Cannon Research Institute and Vanderbilt University, where she conducted cancer research.

Her expertise spans strategic product innovation, tactical regulatory approaches, and identifying unmet medical needs. Dr. Macias-Perez has made significant contributions to the field of oncology and rare disease research, with numerous publications and presentations at national conferences. She has also received grants from the FDA Orphan Product Division for clinical trials. Included with several honors and awards received throughout her career is the President’s Award from Cumberland Pharmaceuticals. She holds a Ph.D. from Vanderbilt University in Cancer Biology and an M.S. and B.A. from the University of South Florida.